Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia’s surveillance system performance안전한 개방: 호주의 감시 시스템 성능 평가를 기반으로 한 지속적인 COVID-19 관리를 위한 공중 보건 시스템 요구 사항Article Published on 2022-04-152022-09-11 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 치료기술, [키워드] acute respiratory illness acute respiratory syndrome acute respiratory syndrome coronavirus Analysis available data average Characteristics Cluster Community community transmission coronavirus coronavirus disease Coronavirus disease 2019 Coverage COVID-19 Critical described detection eliminated Engagement epidemiological epidemiologically evaluated FIVE General population genomic sequencing Government increase in International maintenance management mechanism opening Other outbreak Outbreaks performed positive Public public health public health measure quarantine SARS-CoV-2 sensitivity sequencing data severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 state study period Support supported Surveillance symptomatic Timeliness to define Transmission vaccination Vaccine variant variants variants of concern VOCs was tested [DOI] 10.1186/s12916-022-02344-x PMC 바로가기 [Article Type] Article
Response to and outcomes of the Pfizer BNT162B2 vaccine in hemodialysis patients-A prospective observational studyObservational Study Published on 2022-04-012022-10-05 Journal: Hemodialysis International. International Symposiu [Category] COVID19(2023년), SARS, 임상, [키워드] Antibody Response Antibody titer BNT162b2 vaccine COVID-19 COVID-19 infection COVID-19 vaccine death dialysis DiaSorin dose evaluated FIVE Hemodialysis high mortality Hospitalization Hospitalized IgG IgG test in both group Infection Italy LIAISON non-responder occurred outcome Patient patients Pfizer prospective observational study Protective rate of infection required Research Responder responders response S1/S2 SARS-CoV-2 SARS-CoV2 second dose Standard the vaccine vaccination Vaccine vaccine response was tested was used [DOI] 10.1111/hdi.13005 PMC 바로가기 [Article Type] Observational Study
Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies Among Vaccinated Populations백신 접종 집단 사이의 혈청유병성 연구에서 자연적인 SARS-CoV-2 감염의 확인Article Published on 2022-04-012022-09-11 Journal: Mayo Clinic proceedings [Category] COVID19(2023년), MERS, SARS, 진단, 치료법, [키워드] 95% CI Accuracy age All participants an area antibody Antibody assays Antibody testing Area Blood can not capillary capillary blood Cohort composed conducted determine determined by elevated enrolled enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay female Health care Health care worker health care workers identification IgG IgG antibodies IgG antibody IgGs individual individuals Infection MOST natural natural infection nucleocapsid nucleocapsid protein participant Participants performed Population predicted Protein reactive reactivity reported SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 nucleocapsid separated Seroprevalence significantly specificity Spike protein Spike proteins statistically vaccinated individuals vaccination Vaccination Status was determined was tested were assessed [DOI] 10.1016/j.mayocp.2022.02.002 PMC 바로가기 [Article Type] Article
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records전자 건강 기록을 사용한 COVID-19 mRNA 백신 3회 접종의 안전성 감시Article Published on 2022-04-012022-09-12 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI addition Administered Adverse adverse event adverse events age analyzed anaphylaxis approval arthralgia BNT162b2 booster vaccination booster vaccinations chill clinical trials Cohort cohort study cohorts comparable conducted control groups COVID-19 COVID-19 mRNA vaccine COVID-19 mRNA vaccines criteria diarrhea dose drug EHR eligible evaluate fatigue Fever food headache Health increased risk individual individuals Mayo Clinic median mRNA mRNA vaccine mRNA-1273 myalgia myocarditis nausea outcome participant profile quantified receiving recent Record regimen remained reported Reporting risk Safety SARS-COV-2 infection second dose severe adverse event study inclusion study participant thrombosis vaccination Vaccine vaccine dose Vaccine-induced immunity venous vomiting was tested were assessed [DOI] 10.1001/jamanetworkopen.2022.7038 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial합성 다항원 변형 백시니아 바이러스 앙카라 기반 COVID-19 백신(COH04S1)의 안전성 및 면역원성: 공개 및 무작위 배정, 1상 시험Clinical Trial Published on 2022-04-012022-09-11 Journal: The Lancet. Microbe [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료법, [키워드] 95% CI Administered Adults Analysis Anxiety assigned baseline body-mass body-mass index boost Cellular responses center city Cohort Comprehensive Concentration COVID-19 vaccine development dose drug eight fatigue female Fever Fisher Fisher's exact test FIVE followed by foundation Future GRADE grade 3 Haematology healthy High dose High-dose Hope IgG immunogenicity immunological increase in initiated injection interferon interferon-γ Intramuscular injection less limit low dose low-dose medium dose modified vaccinia virus modified vaccinia virus Ankara Moss negative pregnancy test nine nucleocapsid nucleocapsid antigens nucleocapsid protein nucleocapsid-specific antibody Open-label outcome participant PCR test Phase 1 phase 1 trial Placebo placebo group plaque-forming unit plaque-forming units poxvirus pregnancy test Primary outcome provided randomised Randomly receive Registered reported risk Safety SARS-CoV-2 antibody SARS-CoV-2 neutralising antibodies SARS-CoV-2 neutralising antibody SARS-CoV-2 spike Secondary objectives secondary outcome secreting Seroconversion seroconversion rate seroconversion rates Seven severe adverse event severe adverse events Spike protein statistical T cell T cells T-cell responses titre Tolerability Trial troponin USA vaccination Vaccine Viral viral neutralisation was done was measured was tested [DOI] 10.1016/S2666-5247(22)00027-1 PMC 바로가기 [Article Type] Clinical Trial
Sanitation and customer service strategies implemented during COVID-19 correlated with lower Listeria monocytogenes prevalence in retail delicatessensResearch article Published on 2022-04-012022-10-05 Journal: Food Control [Category] 유전자 메커니즘, [키워드] ANOVA benefit changes in cleaning collected Common clones conducted Contamination correlated COVID-19 COVID-19 pandemic disease transmission evaluate highest indicate Linear regression Listeria Listeria monocytogene Listeria monocytogenes logistic regression model Model pandemic PCR amplification predict predicted Predictive Predictive risk Prevalence Prevent Probability protocol question reduced reduced risk Retail deli risk Sanitation SARS-CoV-2 SARS-CoV-2 transmission Sequencing Seven Spread Squeegee statistical statistical model survey Transmission was tested whole genome [DOI] 10.1016/j.foodcont.2021.108701 [Article Type] Research article
A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students대학생을 대상으로 SARS-CoV-2 혈청전환 및 연쇄 바이러스 검사를 측정한 코호트 연구Article Published on 2022-03-312022-09-11 Journal: BMC Infectious Diseases [Category] MERS, SARS, 진단, 치료기술, 치료법, 치료제, [키워드] Abbott Anti-spike antibody Antibody decline Antibody Response Architect assays asymptomatic infection asymptomatic infections Cohort cohort study collected Decline detect difference examined help IgG IgG antibodies immune protection IMPROVE incidence individual Infection majority positive provided reported Result SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 serology Seroconversion seroconverted serology testing seropositive Seroprevalence serum Surveillance Symptom symptom data symptomatic infection symptomatic infections target the antibody response the SARS-CoV-2 threshold Viral was tested [DOI] 10.1186/s12879-022-07314-5 PMC 바로가기 [Article Type] Article
Effect of Short Time of SARS-CoV-2 Infection in Caco-2 CellsCaco-2 세포에서 SARS-CoV-2 감염의 짧은 시간 효과Article Published on 2022-03-292022-09-11 Journal: Viruses [Category] SARS, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 affecting Caco-2 Caco-2 cell Caco-2 cell line Caco-2 cells Cell cell line children clinical manifestation clinical manifestations coronavirus coronavirus disease coronavirus disease 19 COVID-19 Cytopathic effect Effect epithelial cell epithelial cell line gastrointestinal tract highlight immunofluorescence immunofluorescence staining in vitro include infect intestinal multiplicity multiplicity of infection SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus short time of infection staining subsequent the viral nucleocapsid these cell These cells time viral absorption. was tested [DOI] 10.3390/v14040704 PMC 바로가기 [Article Type] Article
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years – PROTECT Cohort, July 2021-February 20225-11세 아동 및 12-15세 청소년 사이에서 SARS-CoV-2 감염 예방에 2회분 BNT162b2(Pfizer BioNTech) mRNA 백신의 효과 - PROTECT 코호트, 2021년 7월-2022년 2월Article Published on 2022-03-182022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종, [키워드] 95% CI adjusted Adolescent age average B.1.1.529 B.1.617.2 BNT162b2 CDC children circulation Committee COVID-19 symptom COVID-19 symptoms COVID-19 vaccinations COVID-19 vaccine Delta demonstrated dose doses Effectiveness eligible Frequency group health information Infection laboratory-confirmed SARS-CoV-2 infection less Local location mRNA omicron participant Pfizer Pfizer-BioNTech Practice predominant Preventing prospective cohort real-world data receipt referred to SARS-CoV-2 SARS-COV-2 infection sick social contact Sociodemographic characteristics symptomatic and asymptomatic symptomatic infection Symptoms the United State United States Vaccine variant virus was tested Year [DOI] 10.15585/mmwr.mm7111e1 PMC 바로가기 [Article Type] Article
Network analysis of depressive and anxiety symptoms in adolescents during the later stage of the COVID-19 pandemicArticle Published on 2022-03-102022-10-04 Journal: Translational Psychiatry [Category] MERS, 치료법, [키워드] Affect Analysis Anxiety anxiety symptom anxiety symptoms approach bootstrap Characteristics characterized complex conducted COVID-19 pandemic Depression depressive depressive symptom effective GAD-7 Gender Generalized ideation Intervention network network analysis PHQ-9 Psychiatric risk Scientific community significantly stability Suicide Symptom Symptoms target Test was tested were assessed Worry [DOI] 10.1038/s41398-022-01838-9 PMC 바로가기 [Article Type] Article